Close Menu

NEW YORK (360Dx) – Diaceutics this week announced a collaboration with Lenovo and Intel to leverage artificial intelligence to determine if patients can be grouped based on diagnostic test information.

By doing so, the partners believe the data can help identify ways of improving diagnosis, treatment, and outcomes for patients sharing similar characteristics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.